Comparative efficacy of antibody-drug conjugates and chemotherapy for malignant tumors: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-01-09
DOI
https://doi.org/10.3389/fonc.2025.1697340
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative efficacy of antibody-drug conjugates and chemotherapy for malignant tumors: a systematic review and meta-analysis

Feiye Zhu, Xiaqiu Wu, Linghui Tao, Xin Gao et al.
Frontiers in Oncology
HER2/EGFR in Cancer Research
article

Comparative efficacy of antibody-drug conjugates and chemotherapy for malignant tumors: a systematic review and meta-analysis

Feiye Zhu, Xiaqiu Wu, Linghui Tao, Xin Gao, Yongsheng Zhang, Wen Hao, Shengxia Lv
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 15
Zhejiang Chinese Medical University (CN), Jining Traditional Chinese Medicine Hospital (CN)
Good health and well-being
Openalex Percentile: Top 94%
HER2/EGFR in Cancer Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparative efficacy of antibody-drug conjugates and chemotherapy for malignant tumors: a systematic review and meta-analysis — Feiye Zhu, Xiaqiu Wu, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS